BitFrontier Capital Holdings, Inc., operating as UNLOCKD Inc., announced a 76% month-over-month revenue increase for its recently acquired subsidiary, Ancient Extracts USA, signaling early commercial momentum as the company transitions toward a revenue-generating wellness platform.
In a commercialization update, UNLOCKD disclosed that preliminary May 2026 revenue for Ancient Extracts reached approximately $22,344, up from $12,670 in April. The company noted that operations under UNLOCKD ownership began in mid-May following the acquisition closing, meaning the reported figure reflects only a partial month of operations. Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with a wholesale order total of about $29,411.
“We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing,” said John P. Gorst, Chief Executive Officer of UNLOCKD. “The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition.”
Ancient Extracts USA offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods under the brand philosophy “Ancient Remedies for Modern Life.” The company believes the brand is positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Management views Ancient Extracts as a capital-efficient operating foundation from which to pursue additional commercialization opportunities, strategic partnerships, and product innovation. Dr. Jordan P. Balencic, Chairman and Chief Science Officer, noted that the acquisition’s attractive characteristics included a differentiated product portfolio, loyal customer base, and multiple growth pathways. “While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity,” he said.
The company also provided an update on its UNLOCKD Technologies division, which has begun preliminary planning for future consumer health technology opportunities. Management has initiated early-stage evaluation of point-of-care testing concepts and engaged in preliminary discussions with developers and potential partners. These initiatives remain conceptual, and the company expects any future technology development to follow a milestone-driven approach with dedicated financing.
All financial figures disclosed are preliminary, unaudited, and subject to adjustment. The company’s strategy focuses on disciplined execution, strengthening operations, expanding distribution, and creating long-term shareholder value through sustainable growth. More information is available at www.unlockdinc.com. Follow @BFCHco on X for verified company updates.
